Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Brain–computer interface
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== Vision ==== Invasive BCI research has targeted repairing damaged sight and providing new functionality for people with paralysis. Invasive BCIs are implanted directly into the [[grey matter]] of the brain during neurosurgery. Because they lie in the grey matter, invasive devices produce the highest quality signals of BCI devices but are prone to [[scar|scar-tissue]] build-up, causing the signal to weaken, or disappear, as the body reacts to the foreign object.<ref>{{cite journal | vauthors = Polikov VS, Tresco PA, Reichert WM | title = Response of brain tissue to chronically implanted neural electrodes | journal = Journal of Neuroscience Methods | volume = 148 | issue = 1 | pages = 1–18 | date = October 2005 | pmid = 16198003 | doi = 10.1016/j.jneumeth.2005.08.015 | s2cid = 11248506 }}</ref> In [[vision science]], direct [[brain implant]]s have been used to treat non-[[congenital]] (acquired) blindness. One of the first scientists to produce a working brain interface to restore sight was private researcher [[William Dobelle]]. Dobelle's first prototype was implanted into "Jerry", a man blinded in adulthood, in 1978. A single-array BCI containing 68 electrodes was implanted onto Jerry's [[visual cortex]] and succeeded in producing [[phosphenes]], the sensation of seeing light. The system included cameras mounted on glasses to send signals to the implant. Initially, the implant allowed Jerry to see shades of grey in a limited field of vision at a low frame-rate. This also required him to be hooked up to a [[mainframe computer]], but shrinking electronics and faster computers made his artificial eye more portable and now enable him to perform simple tasks unassisted.<ref>[https://www.wired.com/wired/archive/10.09/vision.html "Vision quest"]. ''[[Wired (magazine)|Wired]]''. (September 2002).</ref> In 2002, Jens Naumann, also blinded in adulthood, became the first in a series of 16 paying patients to receive Dobelle's second generation implant, one of the earliest commercial uses of BCIs. The second generation device used a more sophisticated implant enabling better mapping of phosphenes into coherent vision. Phosphenes are spread out across the visual field in what researchers call "the starry-night effect". Immediately after his implant, Jens was able to use his imperfectly restored vision to [[driving|drive]] an automobile slowly around the parking area of the research institute.<ref>{{Cite news| vauthors = Kotler S |title=Vision Quest|language=en-US|magazine=Wired|url=https://www.wired.com/2002/09/vision/|access-date=2021-11-10|issn=1059-1028}}</ref> Dobelle died in 2004 before his processes and developments were documented, leaving no one to continue his work.<ref>{{cite web |date=1 November 2004 |title=Dr. William Dobelle, Artificial Vision Pioneer, Dies at 62 |url=https://www.nytimes.com/2004/11/01/obituaries/01dobelle.html |work=The New York Times |vauthors=Tuller D}}</ref> Subsequently, Naumann and the other patients in the program began having problems with their vision, and eventually lost their "sight" again.<ref name="Naumann,_2012">{{cite book | vauthors = Naumann J |title=Search for Paradise: A Patient's Account of the Artificial Vision Experiment. |date=2012 |publisher=Xlibris |isbn=978-1-4797-0920-5}}</ref><ref>{{cite web|author=nurun.com |url=http://www.thewhig.com/2012/11/28/mans-high-tech-paradise-lost |title=Mr. Jen Naumann's high-tech paradise lost |work=thewhig |publisher=Thewhig.com |date= 28 November 2012|access-date=19 December 2016}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)